MedWatch

CEO: Greater chances of more vaccine orders from the US

Danish bank Nordea sees a lot of potential in the Bavarian Nordic share following an increase in orders for the company’s smallpox vaccine from the US. The company’s CEO also sees an increased probability of more orders this year, while the share is on the rise.

Foto: PR Bavarian

The American government is steadily placing more orders for smallpox vaccines in the hands of the Danish biotech company Bavarian Nordic, a sign that even more orders could be underway this year.

That’s the assessment from Bavarian Nordic CEO, Anders Hedegaard, following a recent analysis from the major bank Nordea, in which they are extremely positive towards the company and see great potential in the share.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier